Plus Therapeutics, Inc.
NASDAQEvery share of PSTV (Plus Therapeutics) available to borrow has been lent out. The lending pool is now completely exhausted — availability has dropped to 0%. Cost to borrow stands at 180% annualised, more than double its level a week ago. The cost to borrow hit a recent peak of 242% on May 12. It has since eased slightly to 180%. That…
PSTV short borrow utilization hits 100%, matching its 52-week peak as cost to borrow surges to 179.9% annualized.
Snapshot as of 15 May 2026
Every share of PSTV (Plus Therapeutics) available to borrow has been lent out. The lending pool is now completely exhausted — availability has dropped to 0%. Cost to borrow stands at 180% annualised, more than double…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PSTV — free to start on ORTEX.
Sign up for free →Open PSTV on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live PSTV data →